Literature DB >> 25146088

Racial differences in adipose tissue distribution and risk of aggressive prostate cancer among men undergoing radiotherapy.

Emma H Allott1, Lauren E Howard2, Hai-Jun Song3, Katharine N Sourbeer4, Bridget F Koontz5, Joseph K Salama3, Stephen J Freedland6.   

Abstract

BACKGROUND: Although elevated body mass index (BMI) has been associated with increased risk of aggressive prostate cancer, the importance of adipose tissue distribution is not well understood. We examined associations between overall and visceral obesity and aggressive prostate cancer risk. Moreover, given racial differences in adipose tissue distribution, we examined whether race modified these associations.
METHODS: We conducted a cross-sectional analysis of 308 radiotherapy-treated patients with prostate cancer within the Durham VA from 2005 to 2011. Multivariable logistic regression examined the association between BMI categories and tertiles of waist circumference (WC), visceral fat area (VFA), and periprostatic adipose tissue area (PPAT) with high-grade prostate cancer risk (Gleason score ≥7 vs. ≤6). Models stratified by race examined whether these associations differed between black and nonblack men.
RESULTS: Both elevated BMI (Ptrend = 0.054) and WC (Ptrend = 0.040) were associated with increased high-grade prostate cancer risk, with similar results between races, although the association with BMI was not statistically significant. In contrast, elevated VFA was associated with increased aggressive prostate cancer risk in black men (Ptrend = 0.002) but not nonblack men (Ptrend = 0.831), with a significant interaction between race and VFA (Pinteraction = 0.035). Though similar patterns were observed for PPAT, none was statistically significant.
CONCLUSIONS: Among men undergoing radiotherapy for prostate cancer, visceral obesity is associated with increased aggressive prostate cancer risk, particularly among black men. If confirmed in future studies, these results suggest that adipose tissue distribution differences may contribute to prostate cancer racial disparity. IMPACT: These findings highlight the need to elucidate mechanisms contributing to racial differences in the association between visceral obesity and aggressive prostate cancer. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2014        PMID: 25146088      PMCID: PMC4221530          DOI: 10.1158/1055-9965.EPI-14-0236

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  39 in total

1.  Measurement of waist circumference for retrospective studies - prospective validation of use of CT images to assess abdominal circumference.

Authors:  Alexandru Ciudin; Rafael Salvador; Alex Budoy; Andreea Ciudin; Cristina Spinu; Mihai Gabriel Diaconu; Vlad Constantin; Javier Sánchez; Carlos Nicolau; Antonio Alcaraz
Journal:  Endocrinol Nutr       Date:  2013-12-15

Review 2.  Periprostatic adipose tissue and prostate cancer progression: new insights into the tumor microenvironment.

Authors:  Paul Toren; Vasundara Venkateswaran
Journal:  Clin Genitourin Cancer       Date:  2013-10-24       Impact factor: 2.872

3.  A natural history of weight change in men with prostate cancer on androgen-deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.

Authors:  Howard S Kim; Daniel M Moreira; Matthew R Smith; Joseph C Presti; William J Aronson; Martha K Terris; Christopher J Kane; Christopher L Amling; Stephen J Freedland
Journal:  BJU Int       Date:  2010-09-22       Impact factor: 5.588

4.  Prognostic impact of abdominal adiposity, waist circumference and body mass index in patients with intermediate-risk prostate cancer treated with radiotherapy.

Authors:  T Zilli; T V Nguyen; J-P Bahary; M Chagnon; A Dufresne; D Taussky
Journal:  Int J Obes (Lond)       Date:  2011-01-25       Impact factor: 5.095

5.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

6.  Visceral fat, waist circumference, and BMI: impact of race/ethnicity.

Authors:  Joan F Carroll; Ana L Chiapa; Mayra Rodriquez; David R Phelps; Kathryn M Cardarelli; Jamboor K Vishwanatha; Sejong Bae; Roberto Cardarelli
Journal:  Obesity (Silver Spring)       Date:  2008-01-17       Impact factor: 5.002

7.  Impact of androgen deprivation therapy on weight gain differs by age in men with nonmetastatic prostate cancer.

Authors:  Narhari Timilshina; Henriette Breunis; Shabbir M H Alibhai
Journal:  J Urol       Date:  2012-10-18       Impact factor: 7.450

8.  Periprostatic fat measured on computed tomography as a marker for prostate cancer aggressiveness.

Authors:  Joep G H van Roermund; Gijsbert H Bol; J Alfred Witjes; J L H Ruud Bosch; Lambertus A Kiemeney; Marco van Vulpen
Journal:  World J Urol       Date:  2009-12-22       Impact factor: 4.226

9.  Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition.

Authors:  Tobias Pischon; Heiner Boeing; Steffen Weikert; Naomi Allen; Tim Key; Nina Føns Johnsen; Anne Tjønneland; Marianne Tang Severinsen; Kim Overvad; Sabine Rohrmann; Rudolf Kaaks; Antonia Trichopoulou; Gitaki Zoi; Dimitrios Trichopoulos; Valeria Pala; Domenico Palli; Rosario Tumino; Carlotta Sacerdote; H Bas Bueno-de-Mesquita; Anne May; Jonas Manjer; Peter Wallström; Pär Stattin; Göran Hallmans; Genevieve Buckland; Nerea Larrañaga; María Dolores Chirlaque; Carmen Martínez; María L Redondo Cornejo; Eva Ardanaz; Sheila Bingham; Kay-Tee Khaw; Sabina Rinaldi; Nadia Slimani; Mazda Jenab; Elio Riboli
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

10.  Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006.

Authors:  Catherine C Cowie; Keith F Rust; Earl S Ford; Mark S Eberhardt; Danita D Byrd-Holt; Chaoyang Li; Desmond E Williams; Edward W Gregg; Kathleen E Bainbridge; Sharon H Saydah; Linda S Geiss
Journal:  Diabetes Care       Date:  2008-11-18       Impact factor: 17.152

View more
  14 in total

1.  Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy.

Authors:  Michael S Leapman; Stephen J Freedland; William J Aronson; Christopher J Kane; Martha K Terris; Kelly Walker; Christopher L Amling; Peter R Carroll; Matthew R Cooperberg
Journal:  J Urol       Date:  2016-06-25       Impact factor: 7.450

2.  Body fat distribution on computed tomography imaging and prostate cancer risk and mortality in the AGES-Reykjavik study.

Authors:  Barbra A Dickerman; Johanna E Torfadottir; Unnur A Valdimarsdottir; Edward Giovannucci; Kathryn M Wilson; Thor Aspelund; Laufey Tryggvadottir; Lara G Sigurdardottir; Tamara B Harris; Lenore J Launer; Vilmundur Gudnason; Sarah C Markt; Lorelei A Mucci
Journal:  Cancer       Date:  2019-06-10       Impact factor: 6.860

Review 3.  Obesity and cancer: mechanistic insights from transdisciplinary studies.

Authors:  Emma H Allott; Stephen D Hursting
Journal:  Endocr Relat Cancer       Date:  2015-09-15       Impact factor: 5.678

Review 4.  Obesity and Prostate Cancer: A Focused Update on Active Surveillance, Race, and Molecular Subtyping.

Authors:  Adriana C Vidal; Stephen J Freedland
Journal:  Eur Urol       Date:  2016-10-19       Impact factor: 20.096

5.  Association of Anthropometric Measures with Prostate Cancer among African American Men in the NCI-Maryland Prostate Cancer Case-Control Study.

Authors:  Margaret S Pichardo; Cheryl J Smith; Tiffany H Dorsey; Christopher A Loffredo; Stefan Ambs
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-05-21       Impact factor: 4.254

6.  Clinical effect of multileaf collimator width on the incidence of late rectal bleeding after high-dose intensity-modulated radiotherapy for localized prostate carcinoma.

Authors:  Haruo Inokuchi; Takashi Mizowaki; Yoshiki Norihisa; Kenji Takayama; Itaru Ikeda; Kiyonao Nakamura; Mitsuhiro Nakamura; Masahiro Hiraoka
Journal:  Int J Clin Oncol       Date:  2015-07-12       Impact factor: 3.402

7.  Assessment of causal effects of visceral adipose tissue on risk of cancers: a Mendelian randomization study.

Authors:  Yao Lu; Haibo Tang; Peiyuan Huang; Jie Wang; Peizhi Deng; Yalan Li; Jie Zheng; Liang Weng
Journal:  Int J Epidemiol       Date:  2022-08-10       Impact factor: 9.685

8.  Body Composition and Prostate Cancer Risk: A Systematic Review of Observational Studies.

Authors:  Sarah A Purcell; Camila L P Oliveira; Michelle Mackenzie; Paula Robson; John D Lewis; Carla M Prado
Journal:  Adv Nutr       Date:  2022-08-01       Impact factor: 11.567

9.  Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence: Results from the SEARCH Database.

Authors:  Emma H Allott; Lauren E Howard; William J Aronson; Martha K Terris; Christopher J Kane; Christopher L Amling; Matthew R Cooperberg; Stephen J Freedland
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-01-25       Impact factor: 4.254

10.  Association Between the Body Mass Index and Prostate Cancer at Biopsy is Modified by Genetic Risk: A Cross-Sectional Analysis in China.

Authors:  Gui-Ming Zhang; Yao Zhu; Hai-Tao Chen; Cheng-Tao Han; Fang Liu; Jian-Feng Xu; Ding-Wei Ye
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.